MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202421011858 A) filed by Lupin Limited, Maharashtra, on Feb. 20, 2024, for 'stable ophthalmic pharmaceutical formulation of aflibercept.'
Inventor(s) include Deokar, Vaibhav Dnyaneshwar; Tiwari, Sanjaykumar; Giri, Prashant Dattatraya; Kumbare, Kiran Ramesh; and Pandit, Shubham Rameshrao.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to stable ophthalmic pharmaceutical formulations of aflibercept in a concentration ranging from 10mg/ml to 400mg/ml and one or more pharmaceutically acceptable excipients selected from buffer, stabilizing agents and surfactant."
Disclaimer: Curated by HT Syndication.
